November 18, 2009 – The Centers for Medicaid and Medicare Services (CMS) recently announced it will increase the reimbursement for positron emission tomography (PET) cardiac procedures in 2010.

The final published rule maintains the assignment of all cardiac PET CPT codes to APC 0307 – PET myocardial perfusion imaging, with an increase in the payment for APC 0307 from $1,156.87 in 2009 to $1,432.87 in 2010 – a 24 percent increase from 2009. CMS’s Hospital Outpatient Prospective Payment System (HOPPS) and the 2010 payment rates for procedures continue to package payment for PET radiopharmaceuticals with payment for the imaging procedure (i.e. the nuclear medicine procedure ambulatory payment classifications (APC) payment rate).

The increased reimbursement makes it more economically feasible for groups to adopt cardiac PET, said officials at Bracco Diagnostics Inc., which supplies PET radiotracers. The company said the increase, combined with the current worldwide shortage of the Mo-99 isotope used in SPECT imaging, have created more compelling reasons for physicians and hospitals to implement PET for myocardial perfusion imaging.

PET also offers unique advantages that can be especially beneficial for difficult-to-image patients, including females, those who are obese or require pharmacologic stress testing, and patients with multivessel disease or who have had an equivocal SPECT MPI study.

The final rule established by CMS will be effective for services on or after Jan. 1, 2010.

For more information: www.braccoimaging.com, www.cms.hhs.gov/HospitalOutpatientPPS/HORD/list.asp#TopOfPage


Related Content

News | Radiation Oncology

May 10, 2024 — Mariana Oncology, a fully integrated biotechnology company pioneering a new era of radiopharmaceutical ...

Time May 10, 2024
arrow
News | Prostate Cancer

May 2, 2024 — GT Medical Technologies, Inc. (GT MedTech), a medical device company with the mission of improving the ...

Time May 02, 2024
arrow
News | Proton Therapy

April 29, 2024 — Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today ...

Time April 29, 2024
arrow
News | Radiopharmaceuticals and Tracers

April 5, 2024 — RLS Radiopharmacies, America’s only Joint Commission-accredited radiopharmacy network, today announced ...

Time April 05, 2024
arrow
News | Quality Assurance (QA)

February 12, 2024 — IBA, a world leader in particle accelerator technology and a world-leading provider of dosimetry and ...

Time February 12, 2024
arrow
News | Interventional Radiology

February 6, 2024 — RenovoRx, Inc., a clinical-stage biopharmaceutical company developing novel precision oncology ...

Time February 06, 2024
arrow
News | FDA

January 23, 2024 — Siemens Healthineers announces the Food and Drug Administration (FDA) clearance of syngo Virtual ...

Time January 23, 2024
arrow
News | Radiology Business

January 23, 2024 — Bayer announced Nelson Ambrogio as the new Head of the Radiology Business at its Pharmaceuticals ...

Time January 23, 2024
arrow
News | Magnetic Resonance Imaging (MRI)

January 18, 2024 — Abbott announced that the U.S. Food and Drug Administration (FDA) has approved expanded MRI labeling ...

Time January 18, 2024
arrow
Feature | PET-CT | By Melinda Taschetta-Millane

According to research conducted by Polaris Market Research, the global positron emission tomography (PET)/computed ...

Time January 17, 2024
arrow
Subscribe Now